These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17175342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ.
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mast cells and c-Kit expression in liver allograft rejection.
    El-Refaie AM, Burt AD.
    Histopathology; 2005 Oct; 47(4):375-81. PubMed ID: 16178892
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 7. Mast cell hyperplasia in chronic rejection after liver transplantation.
    O'Keeffe C, Baird AW, Nolan N, McCormick PA.
    Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486
    [Abstract] [Full Text] [Related]

  • 8. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts.
    Borgogna C, Toniutto P, Smirne C, Azzimonti B, Rittà M, Avellini C, Fabris C, Landolfo S, Gariglio M, Pirisi M.
    Histopathology; 2009 Jun; 54(7):837-46. PubMed ID: 19635103
    [Abstract] [Full Text] [Related]

  • 9. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, Arheart K, Berho M, Drachenberg CB, Mendez P, O'Brien C, Jeffers L, Tzakis A, Schiff ER.
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

  • 12. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK.
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [Abstract] [Full Text] [Related]

  • 13. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J.
    Clin Transplant; 2010 Mar; 24(5):701-8. PubMed ID: 20047619
    [Abstract] [Full Text] [Related]

  • 16. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL, Nakhleh RE, Terry LK, Burd EM, Ma CK, Moonka DK, Brown KA, Abouljoud MS.
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation.
    MacQuillan GC, de Boer WB, Allan JE, Platten MA, Reed WD, Jeffrey GP.
    Clin Transplant; 2010 Nov; 24(2):252-8. PubMed ID: 19712085
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
    Asaoka T, Kato T, Marubashi S, Dono K, Hama N, Takahashi H, Kobayashi S, Takeda Y, Takemasa I, Nagano H, Yoshida H, Ruiz P, Tzakis AG, Matsubara K, Monden M, Doki Y, Mori M.
    Liver Transpl; 2009 Dec; 15(12):1738-49. PubMed ID: 19938108
    [Abstract] [Full Text] [Related]

  • 20. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.